Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

In The News

Time to hope for a Lassa fever vaccine?

Gavi

July 15, 2024

Read more

Features

Looking ahead to one of our busiest weeks of the year: IAVI at the International AIDS Conference

July 15, 2024

IAVI leaders will present on why we still need an HIV vaccine and how to engage communities in clinical trials and will launch an Action Plan for accelerating progress on broadly neutralizing antibodies for HIV prevention.

Read more

Scientific Publications

High STI burden among a cohort of adolescents aged 12–19 years in a youth-friendly clinic in South Africa

Read more

Features

IAVI signs lease on new Vaccine Design and Development Lab in Jersey City, NJ

July 10, 2024

New life sciences building to welcome IAVI’s emerging infectious disease vaccine research team.

Read more

In The News

Interview: African scientists on course with Lassa vaccine

NTAi News

July 10, 2024

Read more

Features

Unitaid, IAVI, Medicines Patent Pool, and Wellcome publish novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries

July 5, 2024

With creativity and commitment, changing the status quo to enable access to promising new technologies is possible.

Read more

Features

World Zoonoses Day 2024: IAVI celebrates progress in Lassa vaccine development

July 5, 2024

A series of publications highlight advancements in countermeasures for Lassa fever, an animal-borne illness.

Read more

Press Releases

Advancing toward a preventative HIV vaccine

July 2, 2024

Across four preclinical studies, Scripps Research, IAVI, and additional collaborators make headway in stimulating the rare antibodies needed to fight HIV.

Read more